CD36 is a leukemia stem cell chemoresistance gene and confers an adverse prognosis in acute myeloid leukemia Meeting Abstract
| Authors: | Gonzalez, M. D.; Habeeb, O.; Stranahan, A.; Hu, W.; Devlin, S.; Liu, C.; Arbini, A.; Park, C. |
| Abstract Title: | CD36 is a leukemia stem cell chemoresistance gene and confers an adverse prognosis in acute myeloid leukemia |
| Meeting Title: | 108th Annual Meeting of the United States & Canadian Academy of Pathology (USCAP) |
| Journal Title: | Modern Pathology |
| Volume: | 32 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2019 Mar 16-21 |
| Meeting Location: | National Harbor, MD |
| ISSN: | 0893-3952 |
| Publisher: | Nature Research |
| Date Published: | 2019-03-01 |
| Start Page: | 39 |
| Language: | English |
| ACCESSION: | WOS:000478915501043 |
| PROVIDER: | wos |
| PUBMED: | 30886297 |
| DOI: | 10.1038/s41379-019-0227-7 |
| Notes: | Wenhuo Hu's name is misspelled on the original publication -- Meeting Abstract: 1276 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work